Dupilumab, corticosteroids and their combination for the treatment of bullous pemphigoid
Abstract Background: Conventional systemic corticosteroid therapy for bullous pemphigoid (BP) has been challenged due to severe adverse events. Dupilumab has emerged as an alternative therapeutical option of BP patients. Objectives: To evaluate the efficacy of dupilumab monotherapy and the combina...
Saved in:
| Main Authors: | Guirong Liang, Hua Qian, Chao Sun, Hanmei Zhang, Zhiliang Li, Suo Li, Ke Jing, Chenjing Zhao, Yuan Wang, Ruiyu Xiang, Xiaoguang Li, Suying Feng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Dermatologia
2025-04-01
|
| Series: | Anais Brasileiros de Dermatologia |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962025000200304&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab
by: Liana Victory, MB, BCh, BAO, MRCPI, et al.
Published: (2025-03-01) -
Efficacy and safety of dupilumab in patients with moderate-to-severe bullous pemphigoid: a systematic review and meta-analysis
by: Júlia Opolski Nunes da Silva, et al.
Published: (2025-08-01) -
A Narrative Review of Pemphigoid Diseases: Bridging Associations, Comorbidities, and Management
by: Emma L. Myers, et al.
Published: (2025-05-01) -
Dupilumab Achieves Early Disease Control in Bullous Pemphigoid: A Case Series with TARC-based Biomarker Evaluation
by: Saori Takamura, et al.
Published: (2025-07-01) -
Time to Disease Control with Dupilumab for Bullous Pemphigoid: A Systematic Review and Meta-analysis
by: Laurence Mainville, et al.
Published: (2025-05-01)